Rotavirus infection
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Rotavirus infection
- Therapeutic area
- Infectious Disease
- Rotavirus infection
- Rotavirus caused disease or disorder
- Rotavirus disease or disorder
- Rotavirus infectious disease
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Severe
- MONDO ID
- MONDO:0005194
- Parent condition
- MONDO:0005939
Related records
Broader conditions (8)
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
- Primary viral infectious disease
- Reoviridae infectious disease
- Viral infectious disease
Trials (102)
- A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine
- A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine
- A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
- A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa
- A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia
- A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
- A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.
- A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants
- A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh
- A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.
- A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
- Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants
- Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India
- Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine
- CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults
- CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults
- Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)
- Consistency Lots Vaccine Study (V260-009)
- Does the Fecal Microbiome Influence Rotarix Immunogenicity
- Dose Confirmation Efficacy Study (V260-007)
Approved drugs (2)
Drugs in development (3)
- Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Phase 3
- Maltodextrin Phase 2
- Poliovirus vaccine inactivated Phase 3